Vivos Therapeutics Closes Acquisition of Sod Sciences Stake and 50% Test Interest
Vivos Therapeutics said it closed the acquisition of a stake in Sod Sciences and a 50% interest in the Pseudohypoxia Test. The headline cites a potential path to more than 325,000 new patients through the AHA channel.